Population
6,908,440 patients from 100 observational studies estimating CKD prevalence in general populations globally.
Design
Meta-analysis
Authors
Loading...
High CKD prevalence underscores major CV risk burden requiring clinical vigilance; extends global estimates for targeted research and policy.
CKD has a high global prevalence of 11 to 13%, with the majority being stage 3, representing a significant global health burden and cardiovascular risk factor.
Hill et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: